Honghui Tang | Immunology and Microbiology | Best Researcher Award

Mrs. Honghui Tang | Immunology and Microbiology | Best Researcher Award

Deputy Chief Technician from Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, China

Honghui Tang is an experienced clinical laboratory professional currently serving as the Associate Chief Technician and Supervisor of Clinical Biochemistry at the Clinical Testing Center of the Fourth Affiliated Hospital of Soochow University. With over 21 years of specialized experience, she has developed in-depth expertise in clinical biochemistry and immunological testing. Her career is distinguished by her focus on quality management, laboratory standardization, and diagnostic excellence. She plays a key role in implementing the ISO 15189 accreditation system, designing and enforcing SOP frameworks, and ensuring efficient, accurate, and compliant laboratory operations. Tang is proficient in handling a variety of automated biochemical and immunoassay analyzers and leads the end-to-end diagnostic process. She is also deeply involved in interdepartmental collaboration to resolve complex diagnostic challenges and improve patient care outcomes. As a recognized professional, she serves as a member of the Clinical Biochemistry and Immunology Committee under the Laboratory Medicine Branch of the Suzhou Medical Association. Her leadership, technical competence, and commitment to healthcare advancement position her as a notable contributor in the field of laboratory medicine. While her focus has been more practice-oriented, she remains committed to expanding her engagement with research and evidence-based diagnostics.

Professional Profile

Education

Although the exact educational qualifications are not listed, it is evident that Honghui Tang has undergone advanced academic and professional training to attain the level of Associate Chief Technician in a prestigious clinical setting. Achieving such a role requires a strong educational foundation in clinical laboratory sciences, likely including a bachelor’s degree in Medical Laboratory Technology, Clinical Biochemistry, or a related field, followed by further specialization or advanced diplomas in laboratory diagnostics and quality management systems. Additionally, her ability to lead ISO 15189 implementation efforts and develop comprehensive SOP frameworks suggests extensive continuing education and training in laboratory accreditation protocols, biochemistry techniques, and health sciences management. Such a background is typically supplemented by practical hospital-based internships and certifications in biochemical and immunoassay technologies. As she operates in a university hospital setting and holds a supervisory position, it is also likely that she has participated in professional development programs offered by medical associations and institutional training initiatives. Her academic and technical education has enabled her to navigate complex diagnostic environments while ensuring quality, efficiency, and clinical accuracy.

Professional Experience

Honghui Tang brings over two decades of distinguished professional experience in clinical laboratory medicine, with her current role as Supervisor of Clinical Biochemistry at the Fourth Affiliated Hospital of Soochow University. She has been instrumental in shaping the operational standards of the Clinical Testing Center by implementing quality systems that align with international benchmarks, including ISO 15189. Her core responsibilities span the entire testing process—pre-analytical, analytical, and post-analytical phases—ensuring seamless workflow, error minimization, and clinical reliability. Tang is responsible for managing a wide array of automated instruments, including biochemical and immunoassay analyzers from leading manufacturers. She supervises equipment calibration, maintenance, and troubleshooting, guaranteeing uninterrupted laboratory operations. Her role demands daily interaction with clinicians, which she fulfills by advising on complex test results and refining diagnostic workflows. As a senior member of the laboratory, she also mentors junior staff, conducts training sessions, and enforces strict compliance with established standard operating procedures. Beyond the laboratory setting, she contributes to the broader medical community through her role on the Clinical Biochemistry and Immunology Committee of the Suzhou Medical Association. This combination of technical mastery and leadership underscores her status as a key pillar in her institution’s diagnostic excellence.

Research Interests

While Honghui Tang’s primary expertise lies in clinical laboratory practice, her work intersects significantly with applied research in diagnostic standardization and quality assurance. Her key research interests include the development and validation of diagnostic protocols in clinical biochemistry, the optimization of laboratory workflows for enhanced accuracy, and the implementation of ISO 15189 standards in clinical settings. She is also deeply invested in exploring strategies for minimizing analytical variability, increasing inter-laboratory result harmonization, and improving diagnostic turnaround time. Another area of interest is the clinical interpretation of immunological assay results in complex or ambiguous patient cases, especially in collaborative efforts with physicians for evidence-based medical decision-making. Her contributions have practical implications for diagnostic reliability and healthcare delivery, and her engagement with hospital-wide interdisciplinary case reviews presents unique opportunities for applied clinical research. With the right collaborations, she is well-positioned to contribute to scholarly work on laboratory accreditation, test performance evaluation, and diagnostic technology integration in modern hospital settings. As she continues her career, these research interests could be further developed through collaborative publications, quality improvement studies, and clinical trials focused on diagnostic biomarkers.

Research Skills

Honghui Tang possesses a wide range of advanced research skills rooted in clinical laboratory practice. She is highly proficient in operating and maintaining a variety of automated biochemical and immunoassay analyzers, which is essential for both diagnostic accuracy and research application. Her strengths include data quality management, implementation of international quality standards like ISO 15189, and development of laboratory standard operating procedures (SOPs)—key competencies that support research reproducibility and methodological rigor. Tang also brings expertise in analytical troubleshooting and validation of test results, including root-cause analysis for irregular findings. She is adept in documenting diagnostic workflows, preparing laboratory reports, and contributing to interdepartmental discussions to resolve complex cases. These practical experiences have equipped her with strong skills in data interpretation, assay performance monitoring, and evidence-based evaluation. Additionally, her work supervising other technicians and managing laboratory systems underscores her project management, documentation, and training abilities. Although she has yet to publish widely, her operational expertise provides a strong foundation for translational research and diagnostic innovation. Her technical fluency, especially in relation to test automation and quality assurance, makes her well-prepared to contribute to applied clinical research and collaborative investigations.

Awards and Honors

While no specific awards or honors are mentioned in the available information, Honghui Tang’s appointment as Associate Chief Technician and her leadership role in one of Soochow University’s affiliated hospitals are significant recognitions of her professional contributions. The trust placed in her to lead the Clinical Biochemistry section, oversee quality assurance, and implement accreditation standards such as ISO 15189 attests to her high level of competence and dedication. Furthermore, her selection as a committee member of the Clinical Biochemistry and Immunology Division of the Suzhou Medical Association reflects professional acknowledgment by her peers and industry leaders. These roles typically require demonstrated excellence in laboratory management, technical proficiency, and consistent contribution to healthcare services. Although formal honors such as national or international research awards are not listed, her career achievements indicate that she has earned institutional and professional respect. As she continues to engage more actively in research, particularly through collaborations and publications, she stands to receive additional recognition at the academic and scientific levels in the near future.

Conclusion

Honghui Tang exemplifies excellence in clinical laboratory science through her extensive experience, leadership, and technical acumen. Her 21-year career is marked by a commitment to diagnostic precision, quality management, and the continuous advancement of clinical laboratory operations. As Associate Chief Technician, she plays a pivotal role in standardizing procedures, implementing internationally recognized accreditation systems, and training new professionals. Her ability to operate across technical, managerial, and clinical dimensions makes her a vital contributor to patient care and hospital diagnostics. While her work is largely practice-oriented, she possesses a strong foundation for research, particularly in diagnostic standardization and quality assurance. Moving forward, increased participation in academic research and publication will enhance her professional profile and contribute to the scientific community. With her established expertise, leadership roles, and interest in applied research, Honghui Tang is a highly deserving candidate for the Best Researcher Award in the field of clinical laboratory science. Her work not only improves operational outcomes but also ensures the accuracy and integrity of patient diagnostics, reflecting the critical role of laboratory science in modern healthcare.

 

Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Dr. Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Dr. Jean Michel Bolla is a distinguished researcher specializing in microbiology, biochemistry, and antibiotic resistance. With over 30 years of experience, he has made significant contributions to understanding bacterial resistance mechanisms, particularly efflux-mediated resistance in Gram-negative bacteria. As the Director of Research at Inserm U-1261, he has led pioneering studies in bacterial physiology and virulence, as well as the development of screening platforms for antibiotic-resistant bacteria. His leadership in the Bac-Screen platform, which enables high-throughput screening of antimicrobial compounds, highlights his commitment to innovative research. Dr. Bolla has supervised multiple PhD students and postdoctoral researchers, securing major research funding from national and international agencies. His work has been recognized through invited talks at international conferences and a patent related to diagnostic tools for antibiotic resistance. Additionally, he has contributed significantly to academia through teaching roles at Aix-Marseille Université and Université de Corse. His research continues to shape the field of antimicrobial resistance, addressing one of the most pressing global health challenges. Through his expertise, leadership, and dedication to scientific advancement, Dr. Bolla has established himself as a leading figure in microbiology and antibiotic resistance research.

Professional Profile

Education

Dr. Jean Michel Bolla holds a PhD in Biochemistry and Molecular Biology from UPR9027 CNRS, Marseille, awarded in 1990. His doctoral research focused on protein export and assembly in Escherichia coli, conducted under the supervision of Dr. JM Pagès. Following his PhD, he pursued a postdoctoral fellowship at Inserm-APHP, Paris, where he worked on iron starvation responses in Listeria monocytogenes under Dr. P. Berche. His advanced training includes specialization in Campylobacter porins at the Laboratory Centre for Disease Control in Ottawa and Winnipeg, Canada in 1997 and 1998. In 2001, he obtained his Habilitation à Diriger des Recherches (HDR) from the Faculty of Medicine, Timone, Marseille, enabling him to supervise doctoral research. His extensive academic training has provided him with a strong foundation in molecular microbiology, biochemistry, and antibiotic resistance. Through continuous education and research, Dr. Bolla has developed a deep understanding of bacterial physiology, antimicrobial resistance mechanisms, and drug discovery. His educational background has been instrumental in shaping his career as a leading researcher in microbiology and antibiotic resistance, allowing him to contribute groundbreaking insights to the field.

Professional Experience

Dr. Jean Michel Bolla has had an illustrious career in research, spanning over three decades. He began as a postdoctoral researcher at Inserm-APHP, Paris, before joining Inserm as a Chargé de Recherche in 1992. Over the years, he advanced within Inserm, holding key research positions, and became Director of Research at U-1261 in 2018. He has led major research initiatives, including the establishment of the Bac-Screen platform, a high-throughput screening system for antibiotic resistance studies. From 2007 to 2011, he also served as an Associate Professor at the Université de Corse, where he contributed significantly to teaching and student mentorship. Throughout his career, Dr. Bolla has supervised seven PhD students and three postdoctoral researchers, demonstrating his commitment to training future scientists. He has been an invited speaker at multiple international conferences, sharing his expertise in antibiotic resistance. His ability to secure major research funding, including grants from CNRS, ANR, and FEAMPA, underscores his impact in the field. His leadership roles at Inserm and collaborations with various research institutions have solidified his reputation as an expert in microbiology and antibiotic resistance.

Research Interest

Dr. Jean Michel Bolla’s research primarily focuses on antibiotic resistance mechanisms, with a particular emphasis on efflux-mediated resistance in Gram-negative bacteria. His work explores the physiology and virulence of bacterial pathogens, including Campylobacter jejuni and Listeria monocytogenes. He is deeply involved in drug discovery and screening technologies, having developed the Bac-Screen platform to identify novel antimicrobial compounds and assess their mechanisms of action. His research also extends to bacterial membrane permeability, studying how bacterial outer membrane porins influence antibiotic uptake and resistance. More recently, he has been engaged in synthetic antibacterial polymer development for therapeutic applications. His work contributes to understanding multidrug resistance mechanisms, a major global health challenge, and seeks innovative solutions to combat bacterial infections. Additionally, he collaborates on projects involving diagnostic tools for detecting antimicrobial resistance, aiming to improve early detection and treatment strategies. Through his research, Dr. Bolla strives to bridge the gap between basic microbiology and clinical applications, working towards the development of effective antimicrobial strategies to tackle the increasing threat of drug-resistant bacteria worldwide.

Research Skills

Dr. Jean Michel Bolla possesses a diverse range of research skills, with expertise in molecular microbiology, biochemistry, and antimicrobial resistance. He has extensive experience in protein purification, bacterial physiology studies, and genetic manipulation of bacterial pathogens. His work in high-throughput screening techniques has been pivotal in identifying new inhibitors for efflux pumps in Gram-negative bacteria. He is proficient in drug discovery methodologies, including antibiotic susceptibility testing, mode-of-action studies, and bacterial membrane permeability analysis. Additionally, he has expertise in structural and functional analysis of bacterial outer membrane proteins, which play a crucial role in drug resistance. Dr. Bolla is also skilled in cell culture techniques, bioinformatics, and statistical analysis for interpreting large-scale screening data. His ability to secure major research funding highlights his competence in grant writing and project management. Furthermore, his teaching and mentorship experience demonstrate his ability to train and guide students in advanced microbiology research techniques. His research skills make him a valuable asset in the fight against antimicrobial resistance, as he continues to develop innovative solutions to combat bacterial infections.

Awards and Honors

Dr. Jean Michel Bolla has been recognized for his outstanding contributions to microbiology and antibiotic resistance research. In 2007, he was awarded the Inserm-Université Interface Contract, acknowledging his excellence in research and academic collaboration. His work in antimicrobial resistance has also been recognized through significant research grants from CNRS, ANR, and FEAMPA, underscoring the impact of his studies in drug discovery and bacterial resistance mechanisms. In 2019, his Bac-Screen platform was designated an Aix-Marseille University Technological Platform, a prestigious recognition that was renewed in 2023 for its critical role in antibiotic resistance research. His contributions to the field have also led to an international patent (WO 2023/139263 A1) for a diagnostic tool to detect drug resistance. Additionally, he has been an invited speaker at leading scientific conferences, including GRS-GRC Multidrug Efflux Systems and The 3rd International Electronic Conference on Antibiotics. His expertise and dedication to advancing microbial research have positioned him as a leading scientist in his field, earning him widespread recognition and respect.

Conclusion

Dr. Jean Michel Bolla is a highly accomplished microbiologist with a strong research background in antibiotic resistance and bacterial physiology. His contributions to understanding efflux-mediated resistance in Gram-negative bacteria have had a profound impact on the field. As Director of Research at Inserm U-1261, he has demonstrated exceptional leadership, securing major research funding and spearheading innovative screening platforms for antimicrobial resistance studies. His dedication to mentoring PhD students and postdoctoral researchers underscores his commitment to advancing scientific knowledge. Through his numerous research projects, international collaborations, and conference presentations, he continues to make significant strides in addressing the global challenge of antibiotic resistance. His patent for a diagnostic tool in antimicrobial resistance showcases his ability to translate research into real-world applications. Recognized through awards and honors, Dr. Bolla is a leading expert in microbiology and antimicrobial resistance. His work has positioned him as a key figure in drug discovery and bacterial resistance research, making him a strong contender for the Best Researcher Award. His career is a testament to scientific excellence, innovation, and dedication to global health challenges.

Publications Top Notes

  1. Title: RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria
    Authors: M. Novelli, Marine; J.M. Bolla, Jean Michel
    Year: 2024
    Citations: 5

  2. Title: Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities
    Authors: A. Di Maio, Attilio; H. Olleik, Hamza; É. Courvoisier-Dezord, Élise; M. Maresca, Marc; M. Robin, Maxime
    Year: 2024
    Citations: 1

  3. Title: Antitubercular potential and pH-driven mode of action of salicylic acid derivatives
    Authors: J. Laudouze, Janïs; T. Francis, Thomas; E. Forest, Emma; P. Santucci, Pierre; J.F. Cavalier, Jean-François
    Year: 2024

  4. Title: Synthesis and antimicrobial testing of 5-fluorouracil derivatives
    Authors: M.U. Patil, Mrunal Unmesh; S. Krykun, Serhii; F. Garzino, Frédéric; J.M. Bolla, Jean Michel; M. Camplo, Michel
    Year: 2023
    Citations: 5

  5. Title: The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
    Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; M. Preusse, Matthias; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
    Year: 2022
    Citations: 11

  6. Title: An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains
    Authors: A. Troudi, Azza; J.M. Bolla, Jean Michel; N. Klibi, Naouel; J.M. Brunel, Jean Michel
    Year: 2022
    Citations: 4

  7. Title: The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane
    Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; H. Rodríguez-Villalobos, Héctor; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
    Year: 2022
    Citations: 6

  8. Title: Nanoarchitectonics of Electrically Activable Phosphonium Self-Assembled Monolayers to Efficiently Kill and Tackle Bacterial Infections on Demand
    Authors: S. Carrara, Serena; F. Rouvier, Florent; S. Auditto, Sanjana; J.M. Bolla, Jean Michel; J.M. Raimundo, Jean Manuel
    Year: 2022
    Citations: 6